← Open Payments lookup

ERICA INGRAM: Open Payments

NPI 1306117692 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$649 in 29 payments from 13 companies in 2025. Trend: 2023 $1,610 · 2024 $1,347 · 2025 $649

Food & beverage: $649
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$147
Lundbeck LLC5$109
Supernus Pharmaceuticals, Inc.5$87
Alkermes, Inc.3$64
Vanda Pharmaceuticals Inc.2$56
Janssen Pharmaceuticals, Inc2$45
Otsuka America Pharmaceutical, Inc.1$30
Vertical Pharmaceuticals, LLC1$28
Teva Pharmaceuticals USA, Inc.1$18
Collegium Pharmaceutical, Inc.1$18

Products named: CAPLYTA, REXULTI, Qelbree, ARISTADA, HETLIOZ, SPRAVATO, ABILIFY MAINTENA, Relexxii.

Industry payments across MD — which companies pay providers there.